S&P Global Inc. vs Novo Nordisk A/S
Market cap comparison over time
S&P Global Inc.
$118.9B
Rank #135
Novo Nordisk A/S
$122.6B
Rank #133
Market Cap Over Time
Key Moments
- S&P Global Inc. overtook Novo Nordisk A/S by 2005
- Novo Nordisk A/S overtook S&P Global Inc. by 2007
- S&P Global Inc. overtook Novo Nordisk A/S by 2020
- Novo Nordisk A/S overtook S&P Global Inc. by 2021
- S&P Global Inc. overtook Novo Nordisk A/S by 2025
- Novo Nordisk A/S overtook S&P Global Inc. by 2026
Year-by-Year Comparison
| Year | S&P Global Inc. | Novo Nordisk A/S | Leader |
|---|---|---|---|
| 2026 | $118.9B | $122.6B | Novo Nordisk A/S |
| 2025 | $154.0B | $152.9B | S&P Global Inc. |
| 2024 | $145.7B | $285.3B | Novo Nordisk A/S |
| 2023 | $127.8B | $315.6B | Novo Nordisk A/S |
| 2022 | $96.3B | $209.4B | Novo Nordisk A/S |
| 2021 | $134.4B | $161.6B | Novo Nordisk A/S |
| 2020 | $92.9B | $92.0B | S&P Global Inc. |
| 2019 | $76.5B | $81.6B | Novo Nordisk A/S |
| 2018 | $47.2B | $61.4B | Novo Nordisk A/S |
| 2017 | $46.5B | $67.2B | Novo Nordisk A/S |
| 2016 | $29.2B | $49.6B | Novo Nordisk A/S |
| 2015 | $26.4B | $75.8B | Novo Nordisk A/S |
| 2014 | $23.5B | $48.6B | Novo Nordisk A/S |
| 2013 | $20.4B | $36.5B | Novo Nordisk A/S |
| 2012 | $13.3B | $33.0B | Novo Nordisk A/S |
| 2011 | $10.7B | $23.3B | Novo Nordisk A/S |
| 2010 | $8.5B | $43.8B | Novo Nordisk A/S |
| 2009 | $7.6B | $22.7B | Novo Nordisk A/S |
| 2008 | $5.1B | $9.1B | Novo Nordisk A/S |
| 2007 | $9.3B | $22.1B | Novo Nordisk A/S |
| 2006 | $14.3B | $7.7B | S&P Global Inc. |
| 2005 | $10.7B | $5.7B | S&P Global Inc. |
| 2004 | $9.4B | $9.4B | Novo Nordisk A/S |
| 2003 | $7.0B | $7.5B | Novo Nordisk A/S |
| 2002 | $6.0B | $6.2B | Novo Nordisk A/S |
| 2001 | $5.9B | $10.3B | Novo Nordisk A/S |